GAPDH (1A10A10) Monoclonal Antibody, PE Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bsm-51010m-pe-100ul |
| Product Name | GAPDH (1A10A10) Monoclonal Antibody, PE Conjugated |
| Applications |
WB
|
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | PE |
| Host | Mouse |
| Source | GAPDH recombinant protein is used to produce this monoclonal antibody. |
| Clonality | Monoclonal |
| Clone # | 1A10A10 |
| Isotype | IgG1 |
| Purification | Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purifie |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 2597 |
| Swiss Prot | P04406 |
| Synonyms | G3PD; GAPD; HEL-S-162eP; Glyceraldehyde-3-phosphate dehydrogenase; GAPDH; Peptidyl-cysteine S-nitrosylase GAPDH; CDABP0047; OK/SW-cl.12 |
| Background | Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively. Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis. Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC. Modulates the organization and assembly of the cytoskeleton. Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules (By similarity). Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma treatment assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation. |
| Application Dilution | |
| WB | 1:1000-5000 |
Frequently asked questions
Which applications is GAPDH (1A10A10) Monoclonal Antibody, PE Conjugated (bsm-51010M-PE) validated for, and at what dilution?
bsm-51010M-PE is validated for WB(WB) (1:1000-5000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does GAPDH (1A10A10) Monoclonal Antibody, PE Conjugated (bsm-51010M-PE) react with?
Tested reactivity: Human, Mouse, Rat.
How should bsm-51010M-PE be stored?
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise GAPDH (1A10A10) Monoclonal Antibody, PE Conjugated (bsm-51010M-PE)?
GAPDH recombinant protein is used to produce this monoclonal antibody.
What are the excitation and emission wavelengths of the PE conjugate (bsm-51010M-PE)?
PE on bsm-51010M-PE: excitation / emission 496,564nm/578nm.